KIZOO Technology Capital GmbH

About The Fund

KIZOO Technology Capital GmbH is a venture capital fund based in Karlsruhe, Germany, that specializes in equity investments, particularly in the seed and startup stages of company development. The fund focuses on a wide array of industries including Software (Web Marketplace Saas..), IT (& TMT), Media, Education, Business Solutions, and IoT (& Wearables). A significant aspect of Kizoo's investment thesis revolves around the field of rejuvenation biotechnology, which concentrates on the development of therapies aimed at preventing and reversing age-related diseases by targeting their root cause - the aging process itself. Kizoo supports groundbreaking, potentially transformative technologies that could have a worldwide impact on extending healthy human lifespans. In line with the vision of its parent organization Mira Holding, and its sister organization Forever Healthy, Kizoo has made significant strides in backing companies such as Reservoir Neuroscience, Cyclarity, Elastrin, Revel, MoglingBio, and Cellvie. These portfolio companies are engaged in pioneering work ranging from drug development to address neurodegeneration and atherosclerosis, to therapeutic advancements for rejuvenating aged stem cells and damaged tissue. Kizoo's history in internet space roots have led them to seed and mentor some of Germany's unicorns in Internet & SaaS, although they are no longer making new investments in this area. They remain a major shareholder in several leading companies such as Staffbase, Mambu, MOQO, and Babbel, which are innovating in fields like employee communication, banking technology, shared mobility services, and language learning, respectively. As a venture capital fund, Kizoo continues to look for opportunities that align with their mission of investing in exciting technology and playing an active role in mentoring and developing the next generation of innovative businesses.